152 related articles for article (PubMed ID: 23303495)
1. Hypermutable Pseudomonas aeruginosa in Cystic fibrosis patients from two Brazilian cities.
Lutz L; Leão RS; Ferreira AG; Pereira DC; Raupp C; Pitt T; Marques EA; Barth AL
J Clin Microbiol; 2013 Mar; 51(3):927-30. PubMed ID: 23303495
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.
López-Causapé C; de Dios-Caballero J; Cobo M; Escribano A; Asensio Ó; Oliver A; Del Campo R; Cantón R; Solé A; Cortell I; Asensio O; García G; Martínez MT; Cols M; Salcedo A; Vázquez C; Baranda F; Girón R; Quintana E; Delgado I; de Miguel MÁ; García M; Oliva C; Prados MC; Barrio MI; Pastor MD; Olveira C; de Gracia J; Álvarez A; Escribano A; Castillo S; Figuerola J; Togores B; Oliver A; López C; de Dios Caballero J; Tato M; Máiz L; Suárez L; Cantón R
Int J Antimicrob Agents; 2017 Sep; 50(3):334-341. PubMed ID: 28735882
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
Rees VE; Deveson Lucas DS; López-Causapé C; Huang Y; Kotsimbos T; Bulitta JB; Rees MC; Barugahare A; Peleg AY; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745381
[TBL] [Abstract][Full Text] [Related]
4. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections.
Maciá MD; Blanquer D; Togores B; Sauleda J; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2005 Aug; 49(8):3382-6. PubMed ID: 16048951
[TBL] [Abstract][Full Text] [Related]
5. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation.
Ciofu O; Riis B; Pressler T; Poulsen HE; Høiby N
Antimicrob Agents Chemother; 2005 Jun; 49(6):2276-82. PubMed ID: 15917521
[TBL] [Abstract][Full Text] [Related]
7. Characterization by phenotypic and genotypic methods of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
Li Y; Zhang X; Wang C; Hu Y; Niu X; Pei D; He Z; Bi Y
Mol Med Rep; 2015 Jan; 11(1):494-8. PubMed ID: 25323940
[TBL] [Abstract][Full Text] [Related]
8. Sequence variability and functional analysis of MutS of hypermutable Pseudomonas aeruginosa cystic fibrosis isolates.
Hogardt M; Schubert S; Adler K; Götzfried M; Heesemann J
Int J Med Microbiol; 2006 Aug; 296(4-5):313-20. PubMed ID: 16542874
[TBL] [Abstract][Full Text] [Related]
9. Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection.
López-Causapé C; Rojo-Molinero E; Mulet X; Cabot G; Moyà B; Figuerola J; Togores B; Pérez JL; Oliver A
PLoS One; 2013; 8(8):e71001. PubMed ID: 23951065
[TBL] [Abstract][Full Text] [Related]
10. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants.
Oliver A; Baquero F; Blázquez J
Mol Microbiol; 2002 Mar; 43(6):1641-50. PubMed ID: 11952911
[TBL] [Abstract][Full Text] [Related]
11. Is infection with hypermutable Pseudomonas aeruginosa clinically significant?
Auerbach A; Kerem E; Assous MV; Picard E; Bar-Meir M
J Cyst Fibros; 2015 May; 14(3):347-52. PubMed ID: 25308183
[TBL] [Abstract][Full Text] [Related]
12. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis.
Ferroni A; Guillemot D; Moumile K; Bernede C; Le Bourgeois M; Waernessyckle S; Descamps P; Sermet-Gaudelus I; Lenoir G; Berche P; Taddei F
Pediatr Pulmonol; 2009 Aug; 44(8):820-5. PubMed ID: 19598278
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem-Resistant Pseudomonas aeruginosa in Chronic Lung Infection: Current Resistance Profile and Hypermutability in Patients with Cystic Fibrosis.
Almeida MM; Freitas MT; Folescu TW; Firmida MC; Carvalho-Assef APD; Marques EA; Leão RS
Curr Microbiol; 2021 Feb; 78(2):696-704. PubMed ID: 33404752
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa Isolates From a Cohort of Mexican Children With Cystic Fibrosis Show Adaptation to a Chronic Phenotype.
Rosales-Reyes R; Rodríguez-Alvarado M; Lezana-Fernández JL; Sánchez-Lozano JY; Gayosso-Vázquez C; Jarillo-Quijada MD; Toledano-Tableros JE; Arredondo-Mercado MJ; Alcántar-Curiel MD; Lincopan N; Vidal JE; Lascurain R; Valvano MA; Santos-Preciado JI
Pediatr Infect Dis J; 2020 Oct; 39(10):899-906. PubMed ID: 32453200
[TBL] [Abstract][Full Text] [Related]
15. Genetic determinants of antimicrobial resistance in polymyxin B resistant Pseudomonas aeruginosa isolated from airways of patients with cystic fibrosis.
Simão FA; Almeida MM; Rosa HS; Marques EA; Leão RS
Braz J Microbiol; 2024 Jun; 55(2):1415-1425. PubMed ID: 38619733
[TBL] [Abstract][Full Text] [Related]
16. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy.
Cigana C; Melotti P; Baldan R; Pedretti E; Pintani E; Iansa P; De Fino I; Favari F; Bergamini G; Tridello G; Cirillo DM; Assael BM; Bragonzi A
BMC Microbiol; 2016 Jul; 16(1):142. PubMed ID: 27400750
[TBL] [Abstract][Full Text] [Related]
17. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants.
Ciofu O; Mandsberg LF; Bjarnsholt T; Wassermann T; Høiby N
Microbiology (Reading); 2010 Apr; 156(Pt 4):1108-1119. PubMed ID: 20019078
[TBL] [Abstract][Full Text] [Related]
18. Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis.
Kenna DT; Doherty CJ; Foweraker J; Macaskill L; Barcus VA; Govan JRW
Microbiology (Reading); 2007 Jun; 153(Pt 6):1852-1859. PubMed ID: 17526842
[TBL] [Abstract][Full Text] [Related]
19. Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene.
Prickett MH; Hauser AR; McColley SA; Cullina J; Potter E; Powers C; Jain M
Thorax; 2017 Jan; 72(1):40-47. PubMed ID: 27325751
[TBL] [Abstract][Full Text] [Related]
20. Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland.
Logan C; Habington A; Lennon G; Grogan J; Byrne M; O'Leary J; O'Sullivan N
J Med Microbiol; 2012 Jan; 61(Pt 1):64-70. PubMed ID: 21921114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
